Maybe gets there... such a bargain here hovering around a buck again I couldn't avoid buying more shares. With all the recent chunks of insider purchases and a ridiculously low rev multiple which is .8x less than 1x of 2020 forecasts. And roughly 1.5x from 2019. The end of this year cbdmd mentioned profitability. Revenues expecting to grow over 100% per year at least through 2022. Shares have fallen a whopping 85% in 7 months. Nasty for those who bought and are holding but lucky to add and enter a new position. Return this to 3x rev multiple of 2021 and the stock will be with its peers. 2020 1x rev we see 1.34. I'm a buyer under 1.34. Good luck.
News 
Market Data 
Discover 
